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Mycobacterium bovis caused 3% of human tubercu-
losis cases in southwest Ireland during 1998–2006. Of 11 
M. bovis strains genotyped, 9 belonged to common animal 
spoligotypes. Seven strains were from sputum and poten-
tial sources of human-centered disease transmission. Ten-
locus variable-number tandem repeat typing gave unique 
strain proﬁ  les and would detect disease outbreaks. 
B
ovine tuberculosis occurs worldwide (1–3). It is caused 
by Mycobacterium bovis, a cattle-adapted member of 
the M. tuberculosis complex. M. bovis has the broadest host 
range of pathogenic mycobacteria, infecting domestic and 
wild mammals, and is classiﬁ  ed as a Hazard Group 3 in-
fectious agent (1). Human infection follows ingestion of 
unpasteurized milk or inhalation of droplet nuclei (1). In 
many countries, the risk for M. bovis infection in humans 
has been reduced by a test-and-slaughter program in which 
infected cattle are identiﬁ  ed and culled. This program has 
eradicated M. bovis cattle infection from 11 states of the 
European Union (3). However, the Republic of Ireland and 
its neighbor the United Kingdom have failed to eradicate 
bovine tuberculosis (1,4). In the 1980s, 4%–6% of all cases 
of laboratory-conﬁ  rmed tuberculosis in southwest Ireland 
were caused by M. bovis (5). Our study results suggest that 
this remains a problem in Ireland. 
Molecular typing systems for pathogenic mycobacte-
ria are important for epidemiologic control because they 
enable case-linking and outbreak tracing (6). We report 
a molecular epidemiology study that used spoligotyping, 
mycobacterial interspersed repetitive units–variable-num-
ber tandem repeat (MIRU-VNTR) typing, and region of 
difference (RD) typing of M. bovis strains isolated from 
human residents of Ireland. 
The Study
During 1998–2006, the microbiology laboratory at 
Cork University Hospital obtained M. tuberculosis com-
plex isolates from 501 patients (equivalent to 68.5% of no-
tiﬁ  ed cases) residing in southwest Ireland (counties Cork 
and Kerry); 15 were M. bovis isolates (3%). Eleven of 
these M. bovis strains were available for testing. Seven ad-
ditional isolates obtained over this period (from inoculation 
abscesses) were identiﬁ  ed as M. bovis BCG and not ana-
lyzed. Strains were identiﬁ  ed as M. tuberculosis complex 
by using Accuprobe (Gene-Probe, San Diego, CA, USA) 
and as potential M. bovis strains by pyruvate dependence. 
Deﬁ  nitive identiﬁ  cation was performed at the Mycobacte-
rial Reference Unit in London and was based on absence of 
niacin production and nitrate reductase activity, thiophen-
2-carboxylic acid hydrazide negativity, and pyrazinamide 
resistance (1). DNA extraction was performed as described 
(2). DNA controls were M. tuberculosis H37Rv and M. 
bovis AF2122/97. A 6-locus panel VNTR (exact tandem 
repeat [ETR]-A to ETR-F) (7) was used initially, then a 10-
locus VNTR panel was used (Table 1) (8). Spoligotyping 
was as described by Kamerbeek (9). RD analysis was con-
ducted by the method of Brosch et al. (10) for RD1, RD4, 
RD9, RD10, RD12, RDpan, RD17, N-RD17, and N-RD25. 
This study was reviewed and approved by the Clinical Re-
search Ethics Committee of the Cork Teaching Hospitals 
(Ref ECM 3).
Spoligotype signatures were recorded as binary num-
bers (1 and 0 denoting presence and absence of oligonu-
cleotide spacer, respectively). Signatures were matched 
against the M. bovis spoligotype database (www.mbovis.
org) and the global spoligotype database, SpolDB4. Un-
matched spoligotypes were sent to the M. bovis spoligotype 
database curator for an authoritative name assignment (SB 
number). The discriminatory power of VNTR and spoligo-
typing was calculated by using the Hunter Gaston Discrim-
inatory Index. Two or more spoligotype or VNTR patterns 
with 100% identity were considered a cluster. 
Eight spoligotypes (Table 2) were identiﬁ  ed among 11 
isolates. Two clusters were identiﬁ  ed: 3 strains of SB0140 
(ST683) and 2 strains corresponding to SB0139 (ST680) 
(Table 2). SB0140 (also known as spoligotype A1 or ST1), 
is the most common spoligotype in animals in Ireland and 
the United Kingdom (1,11) (Table 2). SB0139 was previ-
ously detected as an isolate from a cow in Northern Ireland 
in 2000 (SpolDB4; R. Skuce, pers. comm.). Other spoligo-
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 12, December 2008  1931 
Author afﬁ  liations: University College Cork, Cork, Ireland (O. Ojo, 
M.B. Prentice); Cork University Hospital, Cork (S. Sheehan, G.D. 
Corcoran, M.B. Prentice); Veterinary Laboratories Agency Wey-
bridge, Surrey, UK (M. Okker, K. Gover, J. Dale, S.V. Gordon); and 
Health Protection Agency Barts and the London School of Medi-
cine, London, UK (V. Nikolayevsky, T. Brown, F. Drobniewski)
DOI: 10.3201/eid1412.071135
1Current afﬁ  liation: University College Dublin, Dublin, Ireland.types we identiﬁ  ed that had been previously reported in iso-
lates from animals in Ireland were SB0130 (ST691), also 
described as D1 or ST7; SB0142 (ST679), also described 
as A2 or ST2; and SB1047 (not found in SpolDB4). Three 
strains were not found in either of the databases. These 
strains were assigned spoligotypes SB1185, SB1186, 
and SB1187 through the M. bovis spoligotype database. 
SB1186 and SB1187 differed from the ubiquitous SB140 
by absence of spacer 35 and spacers 35 and 37, respec-
tively. Previously reported SB0139, SB0142, and SB1047 
differed from SB0140 by absence of spacers 33, 33–34, and 
35–36, respectively. SB1185 differed from the established 
animal strain SB0130 by the absence of spacers 20–21. 
Six-locus VNTR (ETR-A–ETR-F) showed little varia-
tion. The predominant proﬁ  le (5 strains) was 7-5-5-4*-3-
3.1. All strains except CUH-HB005 had ETR A–F proﬁ  les, 
matching spoligotype SB0140 strains isolated from cattle 
in England and Wales (12). A 10-locus expanded panel de-
rived from loci recently described for Irish zoonotic M. bo-
vis strains (8) improved strain discrimination by producing 
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Table 1. Heterogeneity of each MIRU-VNTR locus of Mycobacterium bovis isolates, southwest Ireland, 1998–2006* 
No. tandem repeat copies 
VNTR locus  Isolate 0123456789 1 0 1 1HGDI
Allelic 
variants 
1895 QUB1895 0 01280000000 0 . 4 7 3
2163a QUB11a 0 00200000045 0 . 6 9 3
2163b QUB11b 0 10280000000 0 . 4 7 3
2165 ETR-A 0 00012080000 0 . 4 7 3
2461 ETR-B 0 00118010000 0 . 4 9 4
2687 MIRU24 0 65000000000 0 . 5 5 2
2996 MIRU26 0 00117200000 0 . 6 0 4
3232 QUB3232 1 00000007111 0 . 6 2 5
3336 QUB3336 0 01630010000 0 . 6 7 4
4052 QUB26 0 0 2 1 80000000 0 . 4 7 3
*MIRU, mycobacterial interspersed repetitive units; VNTR, variable-number tandem repeats; HGDI, Hunter Gaston Discriminatory Index; QUB, Queen’s 
University Belfast; ETR, exact tandem repeat.  
Table 2. Molecular characteristics of strains and clinical and demographic parameters of 11 patients from whom Mycobacterium bovis 
was isolated, southwest Ireland, 1998–2006* 
Patient data 
Study 
no. Spoligotype  SpolDB4†
Mbovis. 
org‡
Other 
name§ 
VNTR 
pattern¶ 
Sex/ 
age, y 
Sample 
site 
Sputum 
smear 
HB002  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑƑƑƑƑ  ST683  SB0140  A1  4-11-4-7-5- 
1-5-8-3-2 
F/81  Sputum + 
HB008  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑƑƑƑƑ  ST683  SB0140  A1  3-10-4-5-5- 
1-5-8-3-4 
F/86  Sputum – 
HB010  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑƑƑƑƑ  ST683  SB0140  A1  4-3-4-7-5- 
1-5-8-3-4 
F/33  Sputum + 
HB011  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑŶŶŶŶŶƑƑƑƑƑ  ST680  SB0139  NA  4-3-4-7-3- 
1-5-8-3-4 
F/29  Sputum + 
HB012  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑŶŶŶŶŶƑƑƑƑƑ  ST680  SB0139  NA  4-10-4-7-4- 
1-5-8-3-4 
M/62  Sputum + 
HB006  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑŶŶŶƑƑƑƑƑ  ND  SB1186  NA  4-11-4-5-5- 
2-5-9-4-4 
M/60  Urine  NA 
HB007  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑƑŶŶƑƑƑƑƑ  ND  SB1047  NA  4-10-3-7-7- 
2-4-x-4-2 
F/74  Neck 
abscess
NA 
HB003  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑƑŶŶŶŶƑƑƑƑƑ  ST679  SB0142  D1  3-11-4-7-5- 
1-6-8-3-4 
M/37  Spinal 
disc 
aspirate
NA 
HB009  ŶŶƑŶŶƑŶƑƑƑƑƑŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑŶƑŶƑƑƑƑƑ  ND  SB1187  NA  4-11-4-7-5- 
2-5-10-4-4 
F/80  Sputum + 
HB001  ŶŶƑŶŶŶŶŶƑŶƑŶŶŶŶƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑƑƑƑƑ  ST691  SB130  A2  2-11-3-7-5- 
2-3-8-2-3 
M/16  Sputum + 
HB005  ŶŶƑŶŶŶŶŶƑŶƑŶŶŶŶƑŶŶŶƑƑŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶŶƑƑƑƑƑ  ND  SB1185  NA  4-10-1-4-5- 
2-6-11-7-4 
M/68  Testis 
biopsy 
sample 
NA 
*VNTR, variable number tandem repeats; +, smear positive by auramine and Ziehl-Neelsen stains; , smear negative by auramine and Ziehl-Neelsen 
stains; NA, not applicable; ND, not described; x, not determined. 
†Spoligotype designation as described in the SpolDB4 database (www.pasteur-guadeloupe.fr/tb). 
‡Spoligotype assignment as described in the Mbovis.org database (www.mbovis.org).  
§Spoligotype assignment (11). 
¶VNTR profile based on a 10-loci scheme for M. bovis strains from Ireland in this order: QUB1895, QUB11a, QUB11b, ETR-A, ETR-B, MIRU 24, MIRU 
26, QUB 3232, QUB 3336, and QUB26 (8).  M. bovis and Human TB, Southwest Ireland
different proﬁ  les for every isolate (Table 1). Hence, VNTR 
typing was able to split the clustered spoligotypes into indi-
vidual proﬁ  les. Analysis of regions of difference conﬁ  rmed 
that none of the strains were derived from M. bovis BCG. 
Conclusions
A recent outbreak report describing sputum-positive 
M. bovis disease transmitted by person-to-person contact 
(6) underlines the need for precise genetic markers of M. 
bovis to aid epidemiologic traceback. We studied strains 
of M. bovis isolated from humans in the Republic of Ire-
land, and we have deﬁ  ned an optimal set of markers using 
a combination of spoligotyping and VNTR. We detected a 
group of isolates (Table 2) of spoligotype SB0140, which 
is predominant in animal strains of M. bovis reported from 
the Republic of Ireland (51.8% of isolates) (11) and the 
United Kingdom (1). It forms the single largest group of M. 
bovis strains isolated from humans in the United Kingdom 
(30%) (1). This group was not reported in a recent series 
of M. bovis isolates from humans in Italy (13) or France 
(14). Indeed, none of the spoligotypes in our survey and 
these reports overlap. Predominant strains by spoligotype 
in animals and those infecting humans in the same country 
are known to be linked (1,13,14). We found 3 novel spo-
ligotypes similar to SB0140 in a small group of patients, 
showing that a wider variety of strains infect humans than 
animals, as described in similar studies (1,2,13). 
In our study, 81% of patients infected were >30 years 
of age (Table 2), comparable with ﬁ  ndings of a previous 
survey of the southwest Ireland population (5). Primary 
infection of this group is likely to have been several de-
cades before diagnosis, and our isolates probably represent 
reactivation of disease acquired earlier in life, effectively a 
record of past prevalence in animals. Spoligotype SB0140 
strains were isolated from 2 patients who were >80 years of 
age, showing that the current predominance of SB0140 in 
animals (11) is therefore of long duration in Ireland, poten-
tially going back 8 decades. 
Molecular typing by insertion sequence (IS) 6110–
based restriction fragment length polymorphism is inade-
quate for M. bovis because of low copy numbers of IS6110. 
A combination of MIRU-VNTR and spoligotyping gives 
better discrimination (15). Traditional 6-locus VNTR (ETR-
A–ETR-F) has been described for typing of M. tuberculosis 
complex strains (7) including M. bovis (2), but an expanded 
panel with an additional 10 loci applied to our strains greatly 
improved discrimination and enabled individual identiﬁ  ca-
tion of each isolate.
Seven of our 11 isolates were from sputum, and 6 were 
detected on direct smear with potential for transmission. A 
VNTR-typing scheme based on the loci established on M. 
bovis isolates from animals (8) would detect M. bovis clus-
ters derived from foodborne outbreaks or horizontal trans-
mission of disease between humans in Ireland. Our study 
provides ways to markedly improve the ability to identify 
and contact-trace future clusters of M. bovis infection in 
humans. 
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